Angiotensinamide
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Angiotensinamide
- DrugBank Accession Number
- DB13517
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Biologic Classification
- Protein Based Therapies
Peptides - Protein Chemical Formula
- Not Available
- Protein Average Weight
- Not Available
- Sequences
- Not Available
- Synonyms
- Angiotensin amide
- Angiotensinamida
- Angiotensinamide
- Angiotensinamidum
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareChloroprocaine The risk or severity of adverse effects can be increased when Angiotensinamide is combined with Chloroprocaine. Levothyroxine Levothyroxine may increase the vasoconstricting activities of Angiotensinamide. Lidocaine The risk or severity of hypertension can be increased when Angiotensinamide is combined with Lidocaine. Liothyronine Liothyronine may increase the vasoconstricting activities of Angiotensinamide. Liotrix Liotrix may increase the vasoconstricting activities of Angiotensinamide. - Food Interactions
- Not Available
Categories
- ATC Codes
- C01CX06 — Angiotensinamide
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- Not Available
- Kingdom
- Organic Compounds
- Super Class
- Organic Acids
- Class
- Carboxylic Acids and Derivatives
- Sub Class
- Amino Acids, Peptides, and Analogues
- Direct Parent
- Peptides
- Alternative Parents
- Not Available
- Substituents
- Not Available
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 7WAL1X78KV
- CAS number
- 53-73-6
References
- General References
- Not Available
- External Links
- ChemSpider
- 8526544
- BindingDB
- 50228199
- ChEBI
- 135950
- ChEMBL
- CHEMBL409803
- Wikipedia
- Angiotensinamide
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at June 23, 2017 20:43 / Updated at December 01, 2022 11:28